Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02860286 |
|---|---|
| Brief Title: | Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma |
| First Submitted : | July 27, 2016 |
| First Submitted that Met QC Criteria : | August 4, 2016 |
| First Posted : | August 9, 2016 (Estimate) |
| Results First Submitted : | November 16, 2020 |
| Results First Submitted that Met QC Criteria : | March 16, 2021 |
| Results First Posted : | April 9, 2021 |
| Last Update Submitted that Met QC Criteria : | March 16, 2021 |
| Last Update Posted : | April 9, 2021 |